Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03539432 · ClinicalTrials.gov registry record · Phase 2
Exploration of Gemfibrozil as a Treatment for AUD
A Phase 2 study, sponsored by The Mind Research Network.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT03539432: Clinical Trial Phase 2 study, sponsored by The Mind Research Network.
NCT03539432 is a Phase 2 study that was terminated before completion, run by The Mind Research Network. The registered enrollment target is 3 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03539432, a Phase 2 study, was terminated before completion, sponsored by The Mind Research Network.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study will examine the efficacy of the medication gemfibrozil in reducing alcohol consumption in individuals with an alcohol use disorder who are seeking treatment for alcohol-related problems. Twenty individuals will be randomized to receive four weeks of either gemfibrozil or placebo and retrospective reports of alcohol use will be collected throughout the trial. In addition, brain imaging measures will be collected at baseline and after two weeks of treatment to determine the effects of gemfibrozil on brain functioning.
Primary Outcome
Average number of standard drinks consumed on drinking days
Interventions
- DRUG Placebo oral capsule
- DRUG Gemfibrozil 600 MG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2018-05-16 |
| Est. Completion | 2018-12-30 |
| Phase | Phase 2 |
Why NCT03539432 stopped before completion
NCT03539432 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo oral capsule is the first listed.
NCT03539432 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03539432 about?
NCT03539432 is a clinical study titled "Exploration of Gemfibrozil as a Treatment for AUD". This study will examine the efficacy of the medication gemfibrozil in reducing alcohol consumption in individuals with an alcohol use disorder who are seeking treatment for alcohol-related problems. Twenty individuals will be randomized to receive four weeks of either gemfibrozil or placebo and retr...
What is the current status of trial NCT03539432?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2018-05-16. Estimated completion is 2018-12-30.
What interventions are being tested in trial NCT03539432?
The interventions under investigation include: Placebo oral capsule (DRUG), Gemfibrozil 600 MG (DRUG).
Who is sponsoring clinical trial NCT03539432?
This trial is sponsored by The Mind Research Network, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03539432's enrollment target sits among peer trials
3 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI